COVID-19 Vaccine Text Outreach

Covid19 Clinical Trial

Official title:

Pragmatic Trial of COVID Vaccine Text Outreach Interventions

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04834726
• Other study ID #: 848696
• Status: Completed
• Phase: N/A
• Start date: April 29, 2021
• Est. completion date: July 6, 2021

Study information

• Verified date: March 2023
• Source: University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach program. The investigators will evaluate different text-based scheduling and messaging approaches informed by behavioral science to increase uptake among eligible patients, including the use of clinician endorsement, opt-out framing, and scarcity.

Description:

This project will evaluate a centralized approach to increasing COVID through direct outreach to eligible patients via text messaging. This pragmatic randomized controlled trial has the following aims:

Aim 1: To conduct systematic large scale text message outreach for vaccine delivery among a defined group of Penn Medicine in a way that advances equity.

Aim 2: To offer different scheduling workflows through text messaging that might increase uptake and reduce disparities.

Aim 3: To compare the equity and efficiency of different messages informed by behavioral science, including PCP endorsement, opt-out framing, and scarcity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 19554
• Est. completion date: July 6, 2021
• Est. primary completion date: June 4, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• patients of Penn Medicine aged 18+ who reside in Philadelphia and who have had at least 1 visit in the past 5 years with a Penn Medicine primary care provider (PCP)

Exclusion Criteria:

• Patients who have completed any dose of the vaccine at Penn Medicine, are currently scheduled to receive the vaccine, have externally documented vaccination records, or have previously received text-message based vaccine outreach.

Related Conditions & MeSH terms

• COVID-19
• Covid19

Intervention

Behavioral:
• Opt-In (Call-Back)
Messaging will include a prompt to agree to scheduling. If patient agrees, the access center will call these patients back to schedule, calling up to 3 times.
• Opt-in (In-Bound)
Messaging will include a prompt to agree to scheduling followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.
• Standard Message
The message describes that the patient is eligible for the COVID vaccine.
• Clinician Endorsement
The message will describe an endorsement from the provider to get the vaccination.
• Scarcity
The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine.
• Opt-Out Framing
This will highlight that a vaccine is reserved for the patient, implying that they need to opt-out.
• Phone Call
The access center will call these patients to schedule their vaccine appointment. These patients will not receive text messaging.

Locations

Country	Name	City	State
United States	Hospital of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dose 1 Completion	Percentage of patients who complete the first dose of the COVID vaccine within 1 month of initial outreach	1 month
Secondary	Dose 1 Completion	Percentage of patients who complete the first dose of the COVID vaccine within 2 months of initial outreach	2 months
Secondary	Vaccine Completion	Percentage of patients who complete the vaccination process within 2 months of initial outreach	2 months